ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
ImageneBio, Inc.
6.53
-0.0500
-0.76%
盘后:
6.53
0.0000
0.00%
17:16 EST
成交量:
7,794.00
成交额:
5.16万
市值:
7,301.65万
市盈率:
-0.74
高:
6.79
开:
6.68
低:
6.51
收:
6.58
52周最高:
19.20
52周最低:
5.70
股本:
1,118.17万
流通股本:
619.93万
量比:
0.82
换手率:
0.13%
股息:
- -
股息率:
- -
每股收益(TTM):
-8.7700
每股收益(LYR):
-0.1236
净资产收益率:
--
总资产收益率:
--
市净率:
0.52
市盈率(LYR):
-52.82
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字:
ImageneBio, Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
12526 High Bluff Drive,Suite 345,San Diego,California,United States
官网:
http://www.inmagenebio.com
邮编:
92130
电话:
858 345 6265
传真:
- -
简介:
ImageneBio, Inc.于2016年3月2日成立为特拉华州公司,总部位于马萨诸塞州波士顿。该公司是一家靶向肿瘤公司,专注于开发针对驱动癌症形成和扩散的关键信号通路的新型癌症疗法。该公司的项目专注于关键的癌症驱动途径,这些途径在科学文献中得到了很好的验证,但缺乏经批准或有效的治疗方法,因此有可能解决高度未满足的医疗需求。通过利用对发现化学、转化科学和以患者为中心的药物开发的深刻理解,该公司建立了一个专注于基因定义或生物标记物驱动的癌症的全资和合作项目的深入渠道,能够针对该公司认为最有可能的特定患者群体对候选产品的治疗作出反应。自2016年开始运营以来,该公司已经发现或开发了5个肿瘤项目,其中包括4个IND研究或临床开发的候选产品。
董事
名称
职位
Kristin Yarema
Chief Executive Officer and Director and Interim Principal Financial Officer
David Bonita
Lead Independent Director
Jonathan Jian Wang
Chair of the Board
Joseph P. Slattery
Director
Otello Stampacchia
Director
Stephen Hui Wang
Director
苏慰国
Director
股东
名称
职位
Kristin Yarema
Chief Executive Officer and Director and Interim Principal Financial Officer
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","market":"US","secType":"STK","nameCN":"ImageneBio, Inc.","latestPrice":6.53,"timestamp":1768597200000,"preClose":6.58,"halted":0,"volume":7794,"hourTrading":{"tag":"盘后","latestPrice":6.53,"preClose":6.53,"latestTime":"17:16 EST","volume":29,"amount":189.37,"timestamp":1768601790609,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007598784194528849,"floatShares":6199299,"shares":11181700,"eps":-8.77,"marketStatus":"休市中","change":-0.05,"latestTime":"01-16 16:00:00 EST","open":6.68,"high":6.79,"low":6.51,"amount":51552.130887,"amplitude":0.042553,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.77,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":6.58,"postHourTrading":{"tag":"盘后","latestPrice":6.53,"preClose":6.53,"latestTime":"17:16 EST","volume":29,"amount":189.37,"timestamp":1768601790609,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8156473844464533},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMA\",,,,,undefined,":{"symbol":"IMA","floatShares":6199299,"roa":"--","roe":"--","lyrEps":-0.123616,"volumeRatio":0.8156473844464533,"shares":11181700,"dividePrice":0,"high":6.79,"amplitude":0.042553,"preClose":6.58,"low":6.51,"week52Low":5.7,"pbRate":"0.52","psRate":"91.27","week52High":19.2,"institutionHeld":0,"latestPrice":6.53,"eps":-8.77,"divideRate":0,"volume":7794,"delay":0,"ttmEps":-8.77,"open":6.68,"prevYearClose":6.9,"prevWeekClose":6.94,"prevMonthClose":6.9,"prevQuarterClose":6.9,"fiveDayClose":6.94,"twentyDayClose":6.24,"sixtyDayClose":7.48},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"IMA","fiscalQuarterEnding":"2025/09","expectedEps":-1.47,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-2.91},{"market":"US","date":"2025-07-28","symbol":"IMA","defaultRemindTime":1753709400000,"type":"split","dateTimestamp":1753675200000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2025-07-24","symbol":"IMA","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"盘后","type":"earning","dateTimestamp":1753329600000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-05-08","symbol":"IMA","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.18},{"market":"US","date":"2025-03-06","symbol":"IMA","fiscalQuarterEnding":"2024/12","expectedEps":-0.19,"name":null,"time":"盘前","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"pre","actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0,"hold":0,"sell":0,"strongSell":0.3333,"meanLabel":"BUY","meanPercent":0,"analysts":3,"updateTime":1764133200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMA","date":"2026-01-16","current":-0.744584,"percent":0.845455,"low":-8.134224,"twenty":-4.626115,"median":-4.109807,"eighty":-1.664635,"high":-1.428237,"avg":-3.792251,"sd":2.025998,"marketCap":70083290},"quantilePoints":[{"date":"2025-08-15","current":-8.134224,"twenty":-8.112228,"median":-8.06823,"eighty":-8.016532,"marketCap":165376899},{"date":"2025-08-22","current":-7.269609,"twenty":-8.089126,"median":-7.938985,"eighty":-7.265478,"marketCap":157437913},{"date":"2025-08-29","current":-6.949498,"twenty":-8.071529,"median":-7.347055,"eighty":-7.207651,"marketCap":150505278},{"date":"2025-09-05","current":-4.362798,"twenty":-8.06823,"median":-7.269609,"eighty":-7.002161,"marketCap":94485111},{"date":"2025-09-12","current":-4.750028,"twenty":-7.913135,"median":-7.165056,"eighty":-4.777909,"marketCap":102871364},{"date":"2025-09-19","current":-4.311167,"twenty":-7.809737,"median":-7.03727,"eighty":-4.615789,"marketCap":93366944},{"date":"2025-09-26","current":-4.016872,"twenty":-7.532127,"median":-6.908193,"eighty":-4.311167,"marketCap":86993392},{"date":"2025-10-03","current":-4.460896,"twenty":-7.322272,"median":-4.750028,"eighty":-4.238884,"marketCap":96609628},{"date":"2025-10-10","current":-4.24921,"twenty":-7.284065,"median":-4.672583,"eighty":-4.255406,"marketCap":92025144},{"date":"2025-10-17","current":-3.918773,"twenty":-7.257217,"median":-4.460896,"eighty":-4.122198,"marketCap":84868875},{"date":"2025-10-24","current":-3.815512,"twenty":-7.248956,"median":-4.418301,"eighty":-4.002415,"marketCap":82632541},{"date":"2025-10-31","current":-4.336982,"twenty":-7.148276,"median":-4.396358,"eighty":-4.069535,"marketCap":93926028},{"date":"2025-11-07","current":-4.331819,"twenty":-7.057922,"median":-4.378287,"eighty":-4.107742,"marketCap":93814211},{"date":"2025-11-14","current":-4.300841,"twenty":-7.039335,"median":-4.362798,"eighty":-4.109807,"marketCap":93143311},{"date":"2025-11-21","current":-1.760672,"twenty":-6.984607,"median":-4.334401,"eighty":-3.978665,"marketCap":76154335},{"date":"2025-11-28","current":-1.69911,"twenty":-6.937107,"median":-4.311167,"eighty":-3.941491,"marketCap":73491596},{"date":"2025-12-05","current":-1.66956,"twenty":-6.910259,"median":-4.306004,"eighty":-3.874371,"marketCap":72213481},{"date":"2025-12-12","current":-1.593223,"twenty":-6.057319,"median":-4.275025,"eighty":-1.94191,"marketCap":68911685},{"date":"2025-12-19","current":-1.524274,"twenty":-4.777909,"median":-4.254373,"eighty":-1.770522,"marketCap":65929417},{"date":"2025-12-26","current":-1.44055,"twenty":-4.748995,"median":-4.244047,"eighty":-1.699602,"marketCap":62308092},{"date":"2026-01-02","current":-1.69911,"twenty":-4.744865,"median":-4.207906,"eighty":-1.69911,"marketCap":73491596},{"date":"2026-01-09","current":-1.686797,"twenty":-4.71905,"median":-4.130459,"eighty":-1.664635,"marketCap":72959048},{"date":"2026-01-16","current":-1.62031,"twenty":-4.626115,"median":-4.109807,"eighty":-1.664635,"marketCap":70083290}],"updateTime":1768757143409},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":689254445,"address":"12526 High Bluff Drive,Suite 345,San Diego,California,United States","zipCode":"92130","officePhone":"858 345 6265"},"stockCompanyDetail":{"websiteUrl":"http://www.inmagenebio.com","stockEarnings":[{"period":"1week","weight":-0.0591},{"period":"1month","weight":0.0465},{"period":"3month","weight":-0.134},{"period":"6month","weight":-0.5715},{"period":"1year","weight":-0.6396},{"period":"ytd","weight":-0.0536}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImageneBio, Inc.于2016年3月2日成立为特拉华州公司,总部位于马萨诸塞州波士顿。该公司是一家靶向肿瘤公司,专注于开发针对驱动癌症形成和扩散的关键信号通路的新型癌症疗法。该公司的项目专注于关键的癌症驱动途径,这些途径在科学文献中得到了很好的验证,但缺乏经批准或有效的治疗方法,因此有可能解决高度未满足的医疗需求。通过利用对发现化学、转化科学和以患者为中心的药物开发的深刻理解,该公司建立了一个专注于基因定义或生物标记物驱动的癌症的全资和合作项目的深入渠道,能够针对该公司认为最有可能的特定患者群体对候选产品的治疗作出反应。自2016年开始运营以来,该公司已经发现或开发了5个肿瘤项目,其中包括4个IND研究或临床开发的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.018712},{"month":2,"riseRate":0.25,"avgChangeRate":-0.11454},{"month":3,"riseRate":0,"avgChangeRate":-0.048264},{"month":4,"riseRate":0.2,"avgChangeRate":0.002486},{"month":5,"riseRate":0.6,"avgChangeRate":0.039135},{"month":6,"riseRate":0.6,"avgChangeRate":-0.001759},{"month":7,"riseRate":0.6,"avgChangeRate":-0.047104},{"month":8,"riseRate":0.4,"avgChangeRate":-0.019029},{"month":9,"riseRate":0.2,"avgChangeRate":-0.143792},{"month":10,"riseRate":0.2,"avgChangeRate":-0.077133},{"month":11,"riseRate":0.4,"avgChangeRate":-0.138941},{"month":12,"riseRate":0.4,"avgChangeRate":0.075208}],"exchange":"NASDAQ","name":"ImageneBio, Inc.","nameEN":"ImageneBio, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMA\",market:\"US\",,,undefined,":{"directors":[{"name":"Kristin Yarema","position":"Chief Executive Officer and Director and Interim Principal Financial Officer"},{"name":"David Bonita","position":"Lead Independent Director"},{"name":"Jonathan Jian Wang","position":"Chair of the Board"},{"name":"Joseph P. Slattery","position":"Director"},{"name":"Otello Stampacchia","position":"Director"},{"name":"Stephen Hui Wang","position":"Director"},{"name":"苏慰国","position":"Director"}],"executives":[{"name":"Kristin Yarema","position":"Chief Executive Officer and Director and Interim Principal Financial Officer"}]}}}